Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Biopsy devices market industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 End-use trends
2.1.4 Regional trends
Chapter 3 Biopsy Devices Industry Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry ecosystem analysis
3.2.1 Vendor matrix
3.2.2 Distribution channel analysis
3.2.3 Profit margin trends
3.3 Pricing analysis 2018 – 2032
3.3.1 Pricing analysis, by region
3.3.1.1 North America
3.3.1.2 Europe
3.3.1.3 Asia Pacific
3.3.1.4 Latin America
3.3.1.5 Middle East & Africa
3.4 Industry impact forces
3.4.1 Growth drivers
3.4.1.1 Rising incidence of cancer across the globe
3.4.1.2 Technological advancements in biopsy devicess
3.4.1.3 Favorable reimbursement scenario
3.4.1.4 Increasing awareness regarding breast cancer
3.4.2 Industry pitfalls & challenges
3.4.2.1 Risk of complications after biopsy
3.4.2.2 Dearth of skilled healthcare professionals
3.5 Growth potential analysis
3.5.1 By product
3.5.2 By end-use
3.6 COVID- 19 impact analysis
3.7 Regulatory landscape
3.7.1 U.S.
3.7.2 Europe
3.8 Technology landscape
3.9 Industry eco-system
3.9.1 Current trends in the industry
3.9.2 Start-up scenario
3.10 Porter's analysis
3.11 PESTEL analysis
Chapter 4 Competitive landscape
4.1 Introduction
4.1.1 Boston Scientific Corporation
4.1.2 Medtronic plc
4.1.3 FUJIFILM Holdings Corporation
4.2 Competitive dashboard, 2021
4.3 Company market share, 2021
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Biopsy Devices Market, By Product
5.1 Key segment trends
5.2 Biopsy guidance systems
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Manual
5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.3 Robotic
5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Needle based biopsy guns
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Vacuum-assisted biopsy (VAB) devices
5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3 Fine needle aspiration biopsy (FNAB) devices
5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.4 Core needle biopsy (CNB) devices
5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Biopsy needles
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 Disposable
5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.3 Reusable
5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5 Biopsy forceps
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5.2 General biopsy forceps
5.5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5.3 Hot biopsy forceps
5.5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6 Others
5.6.1 Brushes
5.6.1.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6.2 Curettes
5.6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6.3 Punches
5.6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Biopsy Devices Market, By End-use
6.1 Key segment trends
6.2 Hospitals
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Ambulatory surgical center
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Others
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Biopsy Devices Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.6 Middle East & Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
Chapter 8 Company Profiles
8.1 Boston Scientific Corporation
8.2 Medtronic plc
8.3 FUJIFILM Holdings Corporation
8.4 Becton, Dickinson and Company (BD)
8.5 Cardinal Health
8.6 Olympus Corporation
8.7 Hologic Inc
8.8 Argon Medical Devices, Inc
8.9 B. Braun Melsungen AG
8.10 Devicor Medical Products, Inc. (Danaher Corporation)
8.11 Cook Group Incorporated
8.12 INRAD Inc
8.13 Stryker Corporation
